ArriVent BioPharma, Inc. — SC 13G Filings
8 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by ArriVent BioPharma, Inc. (AVBP), sorted by most recent first. Each row links to the full filing on EdgarLookup. ArriVent BioPharma, Inc. has filed 8 SC 13G documents with the SEC since 2021. To view all SEC filings by ArriVent BioPharma, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000919574-24-007004 | Dec 4, 2024 | — |
| SC 13G | ARRIVENT BIOPHARMA, INC. | 0000902664-24-006621 | Nov 14, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-116708 | Nov 12, 2024 | — |
| SC 13G | — | 0000315066-24-002662 | Nov 12, 2024 | — |
| SC 13G | — | 0002012383-24-003521 | Nov 8, 2024 | — |
| SC 13G | — | 0002012383-24-002199 | Oct 24, 2024 | — |
| SC 13G | — | 0001214659-24-017477 | Oct 11, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001213900-24-013438 | Feb 13, 2024 | — |